/hormone-supplement-overview
Integrative Therapeutics Estrovera overview and review: marketed to support vasomotor symptom comfort. Learn what ERr 731 is and how it works. 156 chars.

Not medical advice. Speak with a healthcare professional before using any medication.

Efficacy information based on publicly available clinical literature and peer-reviewed research.
Integrative Therapeutics Estrovera is marketed as an over-the-counter menopause supplement using a specific rhubarb extract (ERr 731) intended to support comfort from hot flashes and related vasomotor symptoms. It is not a hormone and does not supply systemic estrogen; individual responses to it vary.
According to manufacturer labeling for Integrative Therapeutics Estrovera, the product is a branded menopausal-support formula made by Integrative Therapeutics. Its sole active ingredient is ERr 731, a standardized extract of Siberian rhubarb root. Per a study indexed on PubMed (PMID 37874969), this extract has been evaluated in clinical trials and is among the more researched non-hormonal botanical options for vasomotor symptoms, though study populations and methodologies vary.
Per peer-reviewed literature cited on this page, ERr 731 appears to act as a selective modulator of estrogen receptor beta, meaning it may lightly interact with one type of estrogen receptor without supplying estrogen itself. This proposed mechanism is offered to explain why some users report support for hot flashes, night sweats, sleep disruption, and mild mood-related symptoms; however, individual responses vary and these are structure/function claims under DSHEA, not drug claims.
According to manufacturer labeling for Integrative Therapeutics Estrovera, it is sold as a once-daily tablet containing 4 mg of ERr 731, intended to be taken consistently for several weeks before evaluating benefit. It is widely available in the U.S. as a dietary supplement and does not require a prescription.
As a non-hormonal dietary supplement under DSHEA, Integrative Therapeutics Estrovera works through different mechanisms than prescription hormone therapy. These are different product categories with different evidence bases. Patients exploring options for menopausal symptom support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Integrative Therapeutics Estrovera, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber’s clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.

At Voshell’s Pharmacy, we believe in honest guidance — not hype. Visit us in-store or reach out to speak with a pharmacist who knows you and your health.
Contact UsIntegrative Therapeutics Estrovera is marketed to support comfort during menopause, particularly for vasomotor symptoms such as hot flashes, though individual responses vary and it is not appropriate for every person.
According to manufacturer labeling for Integrative Therapeutics Estrovera, the product’s active ingredient is ERr 731 (a standardized extract of Siberian rhubarb root). Per a study indexed on PubMed (PMID 21887807), ERr 731 was associated with a meaningful but moderate reduction in hot flash frequency and intensity, as well as some improvement in sleep and general menopausal quality-of-life scores, with individual variation in outcomes noted across participants.
Areas where the product is marketed to support:
Areas where expectations should remain measured:
For individuals whose primary concern is hot flashes and who prefer a non-hormonal dietary supplement, Integrative Therapeutics Estrovera is one of the more studied OTC botanical options and may be worth a trial period. Patients exploring options for menopausal symptom support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Integrative Therapeutics Estrovera, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber’s clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.
Per a study indexed on PubMed (PMID 21887807), ERr 731 (rhapontic rhubarb extract) was associated with a reduction in the frequency and intensity of hot flashes in study participants, typically within several weeks of consistent use; individual responses vary and results are not guaranteed.
According to manufacturer labeling for Integrative Therapeutics Estrovera, ERr 731 may help support sleep quality for individuals whose nighttime awakenings are associated with temperature-related vasomotor symptoms; individual responses vary.
Per peer-reviewed literature cited on this page, modest support for mood-related symptoms such as irritability and emotional lability associated with menopause has been reported in some study populations, likely related to steadier vasomotor symptom management; individual responses vary.
According to manufacturer labeling for Integrative Therapeutics Estrovera, ERr 731 is a non-hormonal dietary supplement option that may interact with estrogen receptor beta in a targeted way without supplying systemic estrogen, positioning it as a distinct product category from prescription hormone therapies; a prescriber should determine appropriateness for individual patients.
You don’t have to figure it out alone. Our pharmacists are available to answer questions and help you make an informed choice, based on your needs.

Integrative Therapeutics Estrovera is marketed to support individuals whose primary menopausal concern is vasomotor symptoms such as moderate hot flashes and night sweats and who prefer a non-hormonal, well-studied dietary supplement. It is not marketed primarily for vaginal dryness, low libido, or mood changes.
Per a study indexed on PubMed (PMID 21887807), Estrovera’s active ingredient ERr 731 (rhubarb extract) has been evaluated in randomized, placebo-controlled trials specifically for menopausal vasomotor symptoms. According to manufacturer labeling for Integrative Therapeutics Estrovera, women in those studies experienced reported reductions in hot flash occurrence over 8–12 weeks, though individual responses vary and specific response rates reflect study populations only. Per a study indexed on PubMed (PMID 37874969), this extract is among the more studied non-hormonal botanical options available without a prescription.
According to manufacturer labeling, it is marketed as particularly relevant for:
For individuals whose main goal is support for hot flashes and night sweats without using hormones, Integrative Therapeutics Estrovera is one of the more evidence-referenced OTC dietary supplement choices and may be worth a monitored trial. Patients exploring options for menopausal symptom support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Integrative Therapeutics Estrovera, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber’s clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Learn about Integrative Therapeutics Estrovera dosage, side effects, and cost. Information for your provider conversations.
Learn whether Integrative Therapeutics Estrovera requires a prescription, how it works, and what to know before purchasing.